DUBLIN, Nov. 12, 2024 /PRNewswire/ -- Theravance Biopharma, Inc. ("Theravance Biopharma" or the "Company") (NASDAQ: TBPH) today reported financial and operational results for the third quarter of 2024 ...

Subsequent to quarter-end, closed $30 million in debt financingOCU400 Phase 3 liMeliGhT clinical trial for retinitis pigmentosa (RP) on track to ...

The company is making significant strides in its gene therapy programs, particularly with its lead program, OCU400, which targets retinitis pigmentosa (RP). The therapy has shown ... The anticipation ...

Ocugen (NASDAQ: OCGN) Q3 2024 Earnings Call Nov 08, 2024, 8:30 a.m. ET Good morning and welcome to Ocugen's third quarter 2024 financial results and business update. [Operator instructions] I will now ...

Retinitis pigmentosa (RP), a group of genetic disorders that cause ... retinal degeneration to healthy wild-type mice. Our data facilitate the development of new therapeutic strategies that ...

According to data from GTAO Stats, it saw over 400,000 players within 24 hours. As of now, the number has risen to over 1.5 million players. Halloween week also includes double bonuses and RP ...

U.S. tech companies have warned Vietnam's government that a draft law to tighten rules on data protection and limit data ...

What do Barclaycard credit cards offer? Barclaycard is the largest credit card provider in the UK and offers a wide range of cards to suit different borrowing and spending needs. The Barclaycard ...

Italy's data protection authority said on Tuesday Intesa Sanpaolo had underestimated the seriousness of a data breach incident involving thousands of customers, widely reported to include Prime ...

A plastic surgery practice headquartered in Garden City faced a data breach earlier this year impacting the private ...